A Lancet study is now contradicting India's decision to increase the gap between two doses of Covishield vaccine to 12 to 16 weeks from 6 to 8 weeks, saying reducing the gap increases efficacy. India's own study also says that the Delta variant is now dominant in India and is believed to be behind the deadly second wave.
